According to the U.S. Preventive Services Task Force (USPTF), screening for<unk><unk>  is not recommended. Evaluation for NF-2 should be done in individuals with an apparently sporadic vestibular schwannoma occurring before the age of 30, or a spinal tumor or meningioma occurring at less than 20 years of age.
Acoustic neuroma screening
Temporal arteritis screening
Optic nerve glioma screening
Thyroid nodule screening
Salivary gland tumor screening
Carotid artery stenosis screening
Glaucoma screening
Linitis plastica screening